- DNA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
Ginkgo Bioworks (DNA) CORRESPCorrespondence with SEC
Filed: 22 Feb 21, 12:00am
Goldman Sachs & Co. LLC
200 West Street
New York, New York 10282
February 22, 2021
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jonathan Burr
Re: | Soaring Eagle Acquisition Corp. |
Registration Statement on Form S-1
Filed December 23, 2020, as amended
File No. 333-251661
Dear Mr. Burr:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), the undersigned, for themselves and the several underwriters, hereby joins in the request of Soaring Eagle Acquisition Corp. that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4:00 p.m. New York time on February 23, 2021, or as soon thereafter as practicable.
Pursuant to Rule 460 of the General Rules and Regulations under the Act, the undersigned advise that they intend to distribute approximately 2,250 copies of the Preliminary Prospectus dated February 22, 2021 to prospective underwriters and dealers, institutional investors, retail investors and others.
The undersigned advise that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
* * *
[Signature Page Follows]
Very truly yours, | ||||
Goldman Sachs & Co. LLC | ||||
By: | /s/ Olympia McNerney | |||
Name: | Olympia McNerney | |||
Title: | Managing Director |
[Signature Page to Acceleration Request Letter]